Developer docs
API playgroundTry for free, no card

Search company profiles

Wilk

Full company profile

uuid0003y4d

Namestring
Wilk
Legal namestring
WILK TECHNOLOGIES LTD.
Websiteurl
wilkismilk.com
Company typeenum
Public
Founded yearint
2020
Descriptiontext

Wilk Technologies Ltd. is an Israeli bio-foodtech company that develops cell-cultured milk and milk components produced from mammalian mammary epithelial cells cultivated in bioreactors. The company produces cultured human breast milk (targeted at infant nutrition including preterm newborns), cultured animal milk for conventional dairy applications, and discrete high-value ingredients including cell-cultured milk fat (used in the world's first cell-based yogurt, validated by external labs in November 2022) and human lactoferrin proteins (produced in laboratory testing in 2022). Its technology is anchored in over a decade of proprietary research and protected by U.S. and other patents on laboratory milk production methods and systems.

The company operates as a B2B enterprise technology provider targeting the dairy industry, infant nutrition sector, and adjacent industries (pharmaceuticals and cosmetics) through strategic co-development partnerships and technology licensing. The most significant commercial validation is a strategic investment round in April 2023 led by Danone, with participation from Steakholder Foods (2.5% equity stake for $450,000) and Central Bottling Co. Ltd. Wilk is publicly listed on the Tel Aviv Stock Exchange (ticker: WILK) and is headquartered in Rehovot, Israel. The leadership team comprises CEO Ezra Ella (PhD, Hebrew University), CFO Moran Attar (CPA, prior CFO roles at Tel Aviv/Nasdaq/LSE-listed companies), and CSO Nurit Argov-Argaman, PhD (senior lecturer at Hebrew University with 15 years of lactation physiology research). At ~11-50 employees with cumulative disclosed funding of approximately $1.45M and no reported revenue, Wilk is positioned at the pre-commercial platform-validation stage of the alternative-dairy value chain.

Short descriptiontext

Wilk is an Israeli bio-foodtech company that produces cell-cultured human and animal milk, milk fat, and milk proteins from mammary epithelial cells in bioreactors, targeting infant nutrition, dairy, pharma, and cosmetics applications through B2B licensing and strategic partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersRehovot, Israel
HQ citystring
Rehovot
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cell-cultured milk, cultured dairy products, milk fat production, infant nutrition ingredients, cell-based dairy
Industry4 codes
PRIMARYAFAKAGAI
Cultivated (Cell-Based) Protein Foods Manufacturing
Agriculture & Food Production/Food Processing & Manufacturing/Plant-Based & Alternative Protein Foods Manufacturing
SECONDARYAFAKAKAC
Yogurt & Cultured Dairy Products Manufacturing (Kefir, Sour Cream, Labneh)
SECONDARYAFAKAKAH
Dairy-Based Beverages Manufacturing (Flavored Milk, Lassi, Drinkable Yogurt)
SECONDARYAFAHADAJ
Probiotic/Fermented Functional Cultured Dairy (Added Cultures/Prebiotics) Manufacturing
Agriculture & Food Production/Dairy Processing/Yogurt & Cultured Dairy Products (Kefir, Sour Cream, Labneh)
NAICS code2 codes
  • Dairy Product Manufacturing3115
  • Dairy Product (except Frozen) Manufacturing31151
SIC code1 code
  • Dairy Products2020
Product category
Cell-Cultured Dairy
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Cell-based Milk Ingredients
TypeOne Time License
Description

Wilk produces and sells cell-based milk and milk components for various applications including breastfeeding milk for babies, daily dairy consumption, healthy diets, and milk nutritional components for Pharma and Cosmetics industries.

wilkismilk.com
2Technology Licensing and Partnerships
TypeLicensing Royalties
Description

The company generates revenue through strategic partnerships with major food industry players, licensing its cell-based milk production technology to partners like Danone and Steakholder Foods.

prnewswire.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Wilk develops cell-cultured milk and milk components by cultivating mammary epithelial cells from humans and animals in bioreactors. The company's product portfolio includes cell-based human breast milk, cell-based animal milk, cultured milk fat, cell-based yogurt, and human lactoferrin proteins, serving the dairy, infant nutrition, pharmaceutical, and cosmetics industries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 1L of conventional milk requires 1,000L of water; Cell-based production dramatically reduces water consumption
+2 more records
Product overview1 text field

Wilk is a developer of authentic, cell-cultured human and animal milk and milk components. The company produces a portfolio of products including cell-based human breast milk for infants (including personalized options for preterm babies), cell-based animal milk for dairy consumption, and key milk ingredients like cultured milk fat and human lactoferrin proteins. Wilk's technology enables the production of real milk through cells without relying on animals, maintaining the nutritional profile of conventional milk while addressing sustainability and supply challenges. The company achieved a world first by developing yogurt made with cell-cultured milk fat. All products are produced in laboratory settings using proprietary cell culture technology based on over ten years of research.

Product and service6 records
1Cell-Based Milk (Human)
CategoryCell-cultured milk
Description

Cultured human breast milk produced from mammary epithelial cells, providing personalized nutrition for infants including preterm babies, with all the nutritional benefits of natural breast milk.

2Cell-Based Milk (Animal)
CategoryCell-cultured milk
Description

Cultured animal milk produced from mammary epithelial cells for daily dairy consumption, offering sustainable dairy production without reliance on traditional farming.

3Cell-Cultured Milk Fat
CategoryCell-cultured milk ingredients
Description

Milk fat produced through cell culture technology, used as an ingredient in dairy products like yogurt, maintaining nutritional properties of conventional milk fats.

4Cell-Based Yogurt
CategoryCell-cultured dairy products
Description

World's first yogurt developed with cell-cultured milk fat, validated by external laboratories meeting necessary chemical and biological requirements.

5Human Lactoferrin Proteins
CategoryCell-cultured milk ingredients
Description

Breast milk proteins successfully produced in laboratory settings through cell-based technology, offering potential solutions for infant nutrition including baby formula.

6Personalized Milk Ingredients
CategoryCell-cultured milk ingredients
Description

Fully sterile and independent cell-based milk ingredients that can be customized for nutritional, sensory, and therapeutic needs, produced safely in laboratory environments.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Perfect Day is the leading cell-based dairy protein company, producing animal-free whey and casein proteins via precision fermentation. It is the most direct competitor to Wilk in cellular dairy, having raised hundreds of millions from investors including Danone-adjacent capital and partnering with major CPG brands.

TypeDirect peer
Description

Remilk is an Israeli cell-cultured milk company developing animal-free milk proteins using precision fermentation. It is a geographically and technologically comparable peer to Wilk, both pursuing the same end product (cell-based milk) via different production methods.

TypeDirect peer
Description

TurtleTree Labs is a Singapore-based cellular agriculture company developing cell-cultured milk, including human breast milk components. It directly competes with Wilk in the cell-based human milk ingredient space and targets similar infant nutrition and dairy applications.

TypeDirect peer
Description

Biomilq is a US-based cell-cultured human breast milk company using mammary cell technology. It directly competes with Wilk in the cell-based human breast milk and lactoferrin ingredient space, targeting infant nutrition applications.

TypeEmerging player
Description

The EVERY Company produces animal-free proteins via precision fermentation, originally focused on egg proteins and now expanding into dairy proteins. It represents an emerging competitor in cell-based food proteins with broader protein category coverage than Wilk.

TypeEmerging player
Description

Steakholder Foods is an Israeli cellular agriculture company developing 3D-printed cultivated meat. It is both a strategic investor in Wilk (2.5% stake for $450K) and a peer in the broader cellular agriculture space, with shared technology synergies in biotechnology and printing.

TypeBroad incumbent
Description

Danone is a global dairy and nutrition incumbent that led Wilk's April 2023 strategic investment round. As both an investor and a broad dairy incumbent, Danone is a key strategic partner and potential customer for Wilk's cell-based milk technology, while also representing the conventional dairy competition Wilk aims to disrupt.

TypeEmerging player
Description

Imagindairy is an Israeli precision fermentation company producing animal-free dairy proteins. It is a geographically and technologically comparable emerging peer to Wilk, focused on cell-based milk proteins via a different production modality.

9Future Fields
TypeEmerging player
Description

Future Fields is a Canadian cellular agriculture company developing bioprocess infrastructure (growth media) for cell-based food production. It serves as an enabling technology peer, supplying tools to cellular agriculture companies including Wilk's broader competitive set.

TypeEmerging player
Description

Formo is a German precision fermentation company producing animal-free cheese proteins. While focused on cheese vs. Wilk's milk and yogurt, Formo represents an emerging player in the broader cell-based dairy category targeting similar B2B ingredient opportunities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Wilk

Cell-Cultured Dairywilkismilk.com

Wilk is an Israeli bio-foodtech company that produces cell-cultured human and animal milk, milk fat, and milk proteins from mammary epithelial cells in bioreactors, targeting infant nutrition, dairy, pharma, and cosmetics applications through B2B licensing and strategic partnerships.

What Wilk does

Wilk Technologies Ltd. is an Israeli bio-foodtech company that develops cell-cultured milk and milk components produced from mammalian mammary epithelial cells cultivated in bioreactors. The company produces cultured human breast milk (targeted at infant nutrition including preterm newborns), cultured animal milk for conventional dairy applications, and discrete high-value ingredients including cell-cultured milk fat (used in the world's first cell-based yogurt, validated by external labs in November 2022) and human lactoferrin proteins (produced in laboratory testing in 2022). Its technology is anchored in over a decade of proprietary research and protected by U.S. and other patents on laboratory milk production methods and systems.

The company operates as a B2B enterprise technology provider targeting the dairy industry, infant nutrition sector, and adjacent industries (pharmaceuticals and cosmetics) through strategic co-development partnerships and technology licensing. The most significant commercial validation is a strategic investment round in April 2023 led by Danone, with participation from Steakholder Foods (2.5% equity stake for $450,000) and Central Bottling Co. Ltd. Wilk is publicly listed on the Tel Aviv Stock Exchange (ticker: WILK) and is headquartered in Rehovot, Israel. The leadership team comprises CEO Ezra Ella (PhD, Hebrew University), CFO Moran Attar (CPA, prior CFO roles at Tel Aviv/Nasdaq/LSE-listed companies), and CSO Nurit Argov-Argaman, PhD (senior lecturer at Hebrew University with 15 years of lactation physiology research). At ~11-50 employees with cumulative disclosed funding of approximately $1.45M and no reported revenue, Wilk is positioned at the pre-commercial platform-validation stage of the alternative-dairy value chain.

Wilk firmographics

Firmographics
Name
Wilk
Legal name
WILK TECHNOLOGIES LTD.
Website
https://wilkismilk.com
Company type
Public
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
Wilk is an Israeli bio-foodtech company that produces cell-cultured human and animal milk, milk fat, and milk proteins from mammary epithelial cells in bioreactors, targeting infant nutrition, dairy, pharma, and cosmetics applications through B2B licensing and strategic partnerships.
Ownership category
akta.pro rank

Wilk industry classification

Industry
Product category
Cell-Cultured Dairy
NAICS
Dairy Product Manufacturing (3115), Dairy Product (except Frozen) Manufacturing (31151)
SIC
Dairy Products (2020)
akta.pro industry
PRIMARYAFAKAGAI
Cultivated (Cell-Based) Protein Foods Manufacturing
Agriculture & Food Production/Food Processing & Manufacturing/Plant-Based & Alternative Protein Foods Manufacturing
SECONDARYAFAKAKAC
Yogurt & Cultured Dairy Products Manufacturing (Kefir, Sour Cream, Labneh)
SECONDARYAFAKAKAH
Dairy-Based Beverages Manufacturing (Flavored Milk, Lassi, Drinkable Yogurt)
SECONDARYAFAHADAJ
Probiotic/Fermented Functional Cultured Dairy (Added Cultures/Prebiotics) Manufacturing
Agriculture & Food Production/Dairy Processing/Yogurt & Cultured Dairy Products (Kefir, Sour Cream, Labneh)

Keywords

  • Cell-cultured milk
  • Cultured dairy products
  • Milk fat production
  • Infant nutrition ingredients
  • Cell-based dairy

Where Wilk is headquartered

Location

Headquarters

HQ city
Rehovot
HQ country
Israel
HQ region
Middle East

Offices1 record

Markets served

Wilk business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Cell-based Milk Ingredients: Wilk produces and sells cell-based milk and milk components for various applications including breastfeeding milk for babies, daily dairy consumption, healthy diets, and milk nutritional components for Pharma and Cosmetics industries.
  2. Technology Licensing and Partnerships: The company generates revenue through strategic partnerships with major food industry players, licensing its cell-based milk production technology to partners like Danone and Steakholder Foods.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Wilk product offering

Product offering

Core offering

Wilk develops cell-cultured milk and milk components by cultivating mammary epithelial cells from humans and animals in bioreactors. The company's product portfolio includes cell-based human breast milk, cell-based animal milk, cultured milk fat, cell-based yogurt, and human lactoferrin proteins, serving the dairy, infant nutrition, pharmaceutical, and cosmetics industries.

Product overview

Wilk is a developer of authentic, cell-cultured human and animal milk and milk components. The company produces a portfolio of products including cell-based human breast milk for infants (including personalized options for preterm babies), cell-based animal milk for dairy consumption, and key milk ingredients like cultured milk fat and human lactoferrin proteins. Wilk's technology enables the production of real milk through cells without relying on animals, maintaining the nutritional profile of conventional milk while addressing sustainability and supply challenges. The company achieved a world first by developing yogurt made with cell-cultured milk fat. All products are produced in laboratory settings using proprietary cell culture technology based on over ten years of research.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cell-Based Milk (Human) Cultured human breast milk produced from mammary epithelial cells, providing personalized nutrition for infants including preterm babies, with all the nutritional benefits of natural breast milk.
  • Cell-Based Milk (Animal) Cultured animal milk produced from mammary epithelial cells for daily dairy consumption, offering sustainable dairy production without reliance on traditional farming.
  • Cell-Cultured Milk Fat Milk fat produced through cell culture technology, used as an ingredient in dairy products like yogurt, maintaining nutritional properties of conventional milk fats.
  • Cell-Based Yogurt World's first yogurt developed with cell-cultured milk fat, validated by external laboratories meeting necessary chemical and biological requirements.
  • Human Lactoferrin Proteins Breast milk proteins successfully produced in laboratory settings through cell-based technology, offering potential solutions for infant nutrition including baby formula.
  • Personalized Milk Ingredients Fully sterile and independent cell-based milk ingredients that can be customized for nutritional, sensory, and therapeutic needs, produced safely in laboratory environments.

Quantifiable outcome

  • 1L of conventional milk requires 1,000L of water; Cell-based production dramatically reduces water consumption
  • +2 more outcomes

Companies that use Wilk

Customer profile

Segments3 records

Ideal customer profiles3 records

Wilk technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Wilk partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Wilk competitors and assessment

Company assessment

Direct peers

  • Perfect Day: Perfect Day is the leading cell-based dairy protein company, producing animal-free whey and casein proteins via precision fermentation. It is the most direct competitor to Wilk in cellular dairy, having raised hundreds of millions from investors including Danone-adjacent capital and partnering with major CPG brands.
  • Remilk: Remilk is an Israeli cell-cultured milk company developing animal-free milk proteins using precision fermentation. It is a geographically and technologically comparable peer to Wilk, both pursuing the same end product (cell-based milk) via different production methods.
  • TurtleTree Labs: TurtleTree Labs is a Singapore-based cellular agriculture company developing cell-cultured milk, including human breast milk components. It directly competes with Wilk in the cell-based human milk ingredient space and targets similar infant nutrition and dairy applications.
  • Biomilq: Biomilq is a US-based cell-cultured human breast milk company using mammary cell technology. It directly competes with Wilk in the cell-based human breast milk and lactoferrin ingredient space, targeting infant nutrition applications.

Emerging players

  • The EVERY Company (formerly Clara Foods): The EVERY Company produces animal-free proteins via precision fermentation, originally focused on egg proteins and now expanding into dairy proteins. It represents an emerging competitor in cell-based food proteins with broader protein category coverage than Wilk.
  • Steakholder Foods: Steakholder Foods is an Israeli cellular agriculture company developing 3D-printed cultivated meat. It is both a strategic investor in Wilk (2.5% stake for $450K) and a peer in the broader cellular agriculture space, with shared technology synergies in biotechnology and printing.
  • Imagindairy: Imagindairy is an Israeli precision fermentation company producing animal-free dairy proteins. It is a geographically and technologically comparable emerging peer to Wilk, focused on cell-based milk proteins via a different production modality.
  • Future Fields: Future Fields is a Canadian cellular agriculture company developing bioprocess infrastructure (growth media) for cell-based food production. It serves as an enabling technology peer, supplying tools to cellular agriculture companies including Wilk's broader competitive set.
  • Formo: Formo is a German precision fermentation company producing animal-free cheese proteins. While focused on cheese vs. Wilk's milk and yogurt, Formo represents an emerging player in the broader cell-based dairy category targeting similar B2B ingredient opportunities.

Broad incumbents

  • Danone: Danone is a global dairy and nutrition incumbent that led Wilk's April 2023 strategic investment round. As both an investor and a broad dairy incumbent, Danone is a key strategic partner and potential customer for Wilk's cell-based milk technology, while also representing the conventional dairy competition Wilk aims to disrupt.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Wilk social profiles

Digital presence

Wilk financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Wilk leadership team

Management profile

Number of profiles

Profiles3 records

Wilk funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Wilk M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wilk

What does Wilk do?

Wilk develops cell-cultured milk and milk components by cultivating mammary epithelial cells from humans and animals in bioreactors. The company's product portfolio includes cell-based human breast milk, cell-based animal milk, cultured milk fat, cell-based yogurt, and human lactoferrin proteins, serving the dairy, infant nutrition, pharmaceutical, and cosmetics industries.

Is Wilk a public or private company?

Wilk is a public company. It is classified as public and is currently operating.

When was Wilk founded?

Wilk was founded in 2020. It employs 1 to 10 people.

Where is Wilk based?

Wilk is headquartered in Rehovot, Israel, in the Middle East region.

How does Wilk make money?

Two revenue lines are on record. Cell-based Milk Ingredients are the primary driver. The others are technology Licensing and Partnerships.

Who are Wilk's main competitors?

Direct peers on record are Perfect Day, Remilk, TurtleTree Labs and Biomilq. Emerging players are The EVERY Company (formerly Clara Foods), Steakholder Foods, Imagindairy, Future Fields and Formo. Danone is listed as a broad incumbent.

Does Wilk have an API?

No public API is recorded for Wilk.

What industry is Wilk in?

Wilk's product category is Cell-Cultured Dairy. Its primary akta.pro industry code is AFAKAGAI, Cultivated (Cell-Based) Protein Foods Manufacturing, with a secondary code of AFAKAKAC, Yogurt & Cultured Dairy Products Manufacturing (Kefir, Sour Cream, Labneh). Its NAICS code is 3115 and its SIC code is 2020.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
WsjWSJ’s The Future of EverythingThree startups—Helaina, BIOMILQ, and Wilk—are developing products that mimic components of human breast milk, such as lactoferrin and cell-cultured milk. They have raised tens of millions in funding and plan to launch adult nutrition products first, with infant products expected by 2030. The FDA has not yet established regulations for these products.OnMSFT.comRob Wilk, global head of $10B Microsoft Advertising, to leave the companyRob Wilk, global head of Microsoft Advertising, announced his departure after 8 years. Kya Sainsbury-Carter will take the role immediately. Wilk's new role is undisclosed, and Microsoft Advertising's revenue doubling to $20 billion remains uncertain.dairyreporter.comWilk serves up hybrid yogurt made with cultivated milk fatWilk, an Israeli foodtech startup, developed a low-fat yogurt using its cell-cultured milk fat, with plant-based ingredients. The product was tested in external labs and tasted by a chef, who found it comparable to regular yogurt. The company is now developing cell-cultured human milk fat for infant formula.ZapierFoodtech company, Wilk, creates first cultured milk fat, cell-based yogurtWilk announced the world's first yogurt made with cell-cultured milk fat, validated by external labs. The company plans to use the technology for cultured human milk fat in infant formula, replacing vegetable fats.PR NewswireIn World First, Israeli FoodTech Company Wilk Presents First Cell-based Yogurt Produced with Cultured Milk FatIsraeli FoodTech company Wilk has announced the successful development of the world's first yogurt incorporating cell-cultured milk fat, validated by external laboratories and presented to select members of the Israeli public for tasting. The hybrid product serves as a concept demonstration of the company's cell-culturing technology capabilities for producing dairy components without reliance on animals. Wilk is directing the majority of its resources toward developing cell-cultured human milk fat for infant formula, aiming to replace vegetable fats currently used in formula to improve development outcomes for premature and at-risk infants.foodnavigator.comHybrid yogurt uses cell-cultured milk fat for improved taste and nutritionIsraeli food tech company Wilk is developing a hybrid yogurt that incorporates cell-cultured bovine milk fat, the first food product to use such an ingredient. The company says the cultured fat provides nutritional benefits and replicates dairy texture, with development expected to take about six months. Wilk aims to eventually produce dairy products entirely from cell-cultured ingredients.The JCCan you taste the difference? JC tries out Israeli tech’s foods of the futureA tour of Israeli food-tech startups covers companies like Bee-io, Wilk, Redefine Meat, Hargol, and Mush Foods, which produce plant-based honey, milk, meat, and grasshopper products. The author taste-tested several items, rating them from 3 to 5 out of 5, with Bee-io honey receiving a 3/5.PR NewswireCellular Agriculture Europe Adds Wilk Technologies As First Cell-Cultured Dairy MemberWilk, a developer of cell-based human and animal milk, has joined Cellular Agriculture Europe as the first and currently only dairy company member, with the association now totaling 14 companies since its December 2021 launch. The organization was founded by royal decree from King Philippe of Belgium to help Europe meet growing protein demand through environmentally responsible alternative food production. Both organizations stated aims to advance regulations around cell-based foods and collaborate on industry perception and sustainable food production.GreenqueenIsrael’s Wilk Technologies Earns U.S. Patent Approval For Cultivated Breast and Animal Milk ProcessesIsrael-based Wilk Technologies has been granted a U.S. patent for its proprietary cell-based processes to cultivate both animal and human breast milk. The company is currently focused on research and development to refine these methodologies for commercial-scale sustainable production.PR NewswireWilk Receives U.S. Patent for Cell-Based Milk Production Methods and SystemsWilk, an Israeli biotech company developing cell-based human and animal milk production, has been awarded patent approval by the U.S. Patent and Trademark Office for Methods and Systems for in-Vitro Milk Production, making it the exclusive patent holder for cultured milk and breastmilk production technologies. The patent covers the methods and systems required to produce real milk without animals, including simplified separation of milk components from cultured cells. The company plans future production of both regular cultured milk and human breastmilk containing key components for infant health and development.